New

Bone Morphogenetic Protein Market

2021

Bone Morphogenetic Protein Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Recombinant Human Bone Morphogenetic Protein (rhBMP) - 2, Recombinant Human Bone Morphogenetic Protein (rhBMP) -7, Bone morphogenetic protein 4); Application (Spinal Fusion, Trauma, Reconstructive Surgery, Oral-maxillofacial); End User (Hospitals, Specialty Clinics, Ambulatory Surgery Centers, Academic Research, Others) and Geography

| Report Code: TIPRE00006919 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming

Market Insights

Bone Morphogenetic Protein Market 2028 By Type - 2, Application, End User and Geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET OVERVIEW

Bone morphogenetic proteins (BMPs) are growth factors that belongs to the transforming growth factor beta (TGF- beta) superfamily. Bone Morphogenetic Protein 2, a member of the TGF- beta superfamily of cytokines, has been shown in several studies to inhibit the proliferation of human breast cancer cells. During embryogenesis, it is also involved in the production of bone and cartilage, as well as skeletal development. The key driving factors for the bone morphogenetic protein market are, rising incidences of spinal injuries along with extensive R&D activities for development of effective BMP Therapies.

MARKET SCOPE

The "Global Bone Morphogenetic Protein Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the bone morphogenetic protein market with detailed market segmentation by type, application and end user. The report provides key statistics on the market status of the leading bone morphogenetic protein market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •   Based on type the market is segmented as, recombinant human bone morphogenetic protein (rhBMP) - 2, recombinant human bone morphogenetic protein (rhBMP) -7, bone morphogenetic protein 4.
  •   Based on application the market is segmented as, spinal fusion, trauma, reconstructive surgery, and oral-maxillofacial.
  •   Based on end user the market is segmented as, hospitals, specialty clinics, ambulatory surgery centers, academic research, and others.

MARKET DYNAMICS
Drivers:

  •   Rising incidences of spinal injuries and growing geriatric population across the globe.
  •   Rising applications of morphogenetic proteins along with the benefits offered by morphogenetic proteins as compared to other bone grafting procedures.
  •   Extensive R&D activities for development of effective BMP therapies for management of disorders.

Restraints:

  •   However, off-label use of BMP, product recalls due to reported adverse events, and restricted FDA approval are all limiting factors for the bone morphogenetic protein market.



Get more information on this report :

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The bone morphogenetic protein market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the bone morphogenetic protein market in these regions.

IMPACT OF COVID-19 ON BONE MORPHOGENETIC PROTEIN MARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the bone morphogenetic protein market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from bone morphogenetic protein market are anticipated to lucrative growth opportunities in the future with the rising demand for bone morphogenetic protein in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the bone morphogenetic protein market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •   Medtronic
  •   Merck KGaA
  •   Stryker Corporation
  •   Thermo Fischer Scientific
  •   DePuy Synthes (Johnson and Johnson)
  •   Ember Therapeutics
  •   Integra LifeSciences
  •   R and D Systems
  •   Smith and Nephew
  •   Zimmer Biomet Holdings, Inc.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Bone Morphogenetic Protein Market - By Type
1.3.2 Bone Morphogenetic Protein Market - By Application
1.3.3 Bone Morphogenetic Protein Market - By End User
1.3.4 Bone Morphogenetic Protein Market - By Region
1.3.4.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. BONE MORPHOGENETIC PROTEIN MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS

5. BONE MORPHOGENETIC PROTEIN MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. BONE MORPHOGENETIC PROTEIN MARKET - GLOBAL MARKET ANALYSIS
6.1. BONE MORPHOGENETIC PROTEIN - GLOBAL MARKET OVERVIEW
6.2. BONE MORPHOGENETIC PROTEIN - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE

7. BONE MORPHOGENETIC PROTEIN MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN (RHBMP) - 2
7.3.1. Overview
7.3.2. Recombinant Human Bone Morphogenetic Protein (rhBMP) - 2 Market Forecast and Analysis
7.4. RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN (RHBMP) -7
7.4.1. Overview
7.4.2. Recombinant Human Bone Morphogenetic Protein (rhBMP) -7 Market Forecast and Analysis
7.5. BONE MORPHOGENETIC PROTEIN 4
7.5.1. Overview
7.5.2. Bone morphogenetic protein 4 Market Forecast and Analysis
8. BONE MORPHOGENETIC PROTEIN MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. SPINAL FUSION
8.3.1. Overview
8.3.2. Spinal Fusion Market Forecast and Analysis
8.4. TRAUMA
8.4.1. Overview
8.4.2. Trauma Market Forecast and Analysis
8.5. RECONSTRUCTIVE SURGERY
8.5.1. Overview
8.5.2. Reconstructive Surgery Market Forecast and Analysis
8.6. ORAL-MAXILLOFACIAL
8.6.1. Overview
8.6.2. Oral-maxillofacial Market Forecast and Analysis
9. BONE MORPHOGENETIC PROTEIN MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. SPECIALTY CLINICS
9.4.1. Overview
9.4.2. Specialty Clinics Market Forecast and Analysis
9.5. AMBULATORY SURGERY CENTERS
9.5.1. Overview
9.5.2. Ambulatory Surgery Centers Market Forecast and Analysis
9.6. ACADEMIC RESEARCH
9.6.1. Overview
9.6.2. Academic Research Market Forecast and Analysis
9.7. OTHERS
9.7.1. Overview
9.7.2. Others Market Forecast and Analysis

10. BONE MORPHOGENETIC PROTEIN MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Bone Morphogenetic Protein Market Overview
10.1.2 North America Bone Morphogenetic Protein Market Forecasts and Analysis
10.1.3 North America Bone Morphogenetic Protein Market Forecasts and Analysis - By Type
10.1.4 North America Bone Morphogenetic Protein Market Forecasts and Analysis - By Application
10.1.5 North America Bone Morphogenetic Protein Market Forecasts and Analysis - By End User
10.1.6 North America Bone Morphogenetic Protein Market Forecasts and Analysis - By Countries
10.1.6.1 United States Bone Morphogenetic Protein Market
10.1.6.1.1 United States Bone Morphogenetic Protein Market by Type
10.1.6.1.2 United States Bone Morphogenetic Protein Market by Application
10.1.6.1.3 United States Bone Morphogenetic Protein Market by End User
10.1.6.2 Canada Bone Morphogenetic Protein Market
10.1.6.2.1 Canada Bone Morphogenetic Protein Market by Type
10.1.6.2.2 Canada Bone Morphogenetic Protein Market by Application
10.1.6.2.3 Canada Bone Morphogenetic Protein Market by End User
10.1.6.3 Mexico Bone Morphogenetic Protein Market
10.1.6.3.1 Mexico Bone Morphogenetic Protein Market by Type
10.1.6.3.2 Mexico Bone Morphogenetic Protein Market by Application
10.1.6.3.3 Mexico Bone Morphogenetic Protein Market by End User
10.2. EUROPE
10.2.1 Europe Bone Morphogenetic Protein Market Overview
10.2.2 Europe Bone Morphogenetic Protein Market Forecasts and Analysis
10.2.3 Europe Bone Morphogenetic Protein Market Forecasts and Analysis - By Type
10.2.4 Europe Bone Morphogenetic Protein Market Forecasts and Analysis - By Application
10.2.5 Europe Bone Morphogenetic Protein Market Forecasts and Analysis - By End User
10.2.6 Europe Bone Morphogenetic Protein Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Bone Morphogenetic Protein Market
10.2.6.1.1 Germany Bone Morphogenetic Protein Market by Type
10.2.6.1.2 Germany Bone Morphogenetic Protein Market by Application
10.2.6.1.3 Germany Bone Morphogenetic Protein Market by End User
10.2.6.2 France Bone Morphogenetic Protein Market
10.2.6.2.1 France Bone Morphogenetic Protein Market by Type
10.2.6.2.2 France Bone Morphogenetic Protein Market by Application
10.2.6.2.3 France Bone Morphogenetic Protein Market by End User
10.2.6.3 Italy Bone Morphogenetic Protein Market
10.2.6.3.1 Italy Bone Morphogenetic Protein Market by Type
10.2.6.3.2 Italy Bone Morphogenetic Protein Market by Application
10.2.6.3.3 Italy Bone Morphogenetic Protein Market by End User
10.2.6.4 Spain Bone Morphogenetic Protein Market
10.2.6.4.1 Spain Bone Morphogenetic Protein Market by Type
10.2.6.4.2 Spain Bone Morphogenetic Protein Market by Application
10.2.6.4.3 Spain Bone Morphogenetic Protein Market by End User
10.2.6.5 United Kingdom Bone Morphogenetic Protein Market
10.2.6.5.1 United Kingdom Bone Morphogenetic Protein Market by Type
10.2.6.5.2 United Kingdom Bone Morphogenetic Protein Market by Application
10.2.6.5.3 United Kingdom Bone Morphogenetic Protein Market by End User
10.2.6.6 Rest of Europe Bone Morphogenetic Protein Market
10.2.6.6.1 Rest of Europe Bone Morphogenetic Protein Market by Type
10.2.6.6.2 Rest of Europe Bone Morphogenetic Protein Market by Application
10.2.6.6.3 Rest of Europe Bone Morphogenetic Protein Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Bone Morphogenetic Protein Market Overview
10.3.2 Asia-Pacific Bone Morphogenetic Protein Market Forecasts and Analysis
10.3.3 Asia-Pacific Bone Morphogenetic Protein Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Bone Morphogenetic Protein Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Bone Morphogenetic Protein Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Bone Morphogenetic Protein Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Bone Morphogenetic Protein Market
10.3.6.1.1 Australia Bone Morphogenetic Protein Market by Type
10.3.6.1.2 Australia Bone Morphogenetic Protein Market by Application
10.3.6.1.3 Australia Bone Morphogenetic Protein Market by End User
10.3.6.2 China Bone Morphogenetic Protein Market
10.3.6.2.1 China Bone Morphogenetic Protein Market by Type
10.3.6.2.2 China Bone Morphogenetic Protein Market by Application
10.3.6.2.3 China Bone Morphogenetic Protein Market by End User
10.3.6.3 India Bone Morphogenetic Protein Market
10.3.6.3.1 India Bone Morphogenetic Protein Market by Type
10.3.6.3.2 India Bone Morphogenetic Protein Market by Application
10.3.6.3.3 India Bone Morphogenetic Protein Market by End User
10.3.6.4 Japan Bone Morphogenetic Protein Market
10.3.6.4.1 Japan Bone Morphogenetic Protein Market by Type
10.3.6.4.2 Japan Bone Morphogenetic Protein Market by Application
10.3.6.4.3 Japan Bone Morphogenetic Protein Market by End User
10.3.6.5 South Korea Bone Morphogenetic Protein Market
10.3.6.5.1 South Korea Bone Morphogenetic Protein Market by Type
10.3.6.5.2 South Korea Bone Morphogenetic Protein Market by Application
10.3.6.5.3 South Korea Bone Morphogenetic Protein Market by End User
10.3.6.6 Rest of Asia-Pacific Bone Morphogenetic Protein Market
10.3.6.6.1 Rest of Asia-Pacific Bone Morphogenetic Protein Market by Type
10.3.6.6.2 Rest of Asia-Pacific Bone Morphogenetic Protein Market by Application
10.3.6.6.3 Rest of Asia-Pacific Bone Morphogenetic Protein Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Bone Morphogenetic Protein Market Overview
10.4.2 Middle East and Africa Bone Morphogenetic Protein Market Forecasts and Analysis
10.4.3 Middle East and Africa Bone Morphogenetic Protein Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Bone Morphogenetic Protein Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Bone Morphogenetic Protein Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Bone Morphogenetic Protein Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Bone Morphogenetic Protein Market
10.4.6.1.1 South Africa Bone Morphogenetic Protein Market by Type
10.4.6.1.2 South Africa Bone Morphogenetic Protein Market by Application
10.4.6.1.3 South Africa Bone Morphogenetic Protein Market by End User
10.4.6.2 Saudi Arabia Bone Morphogenetic Protein Market
10.4.6.2.1 Saudi Arabia Bone Morphogenetic Protein Market by Type
10.4.6.2.2 Saudi Arabia Bone Morphogenetic Protein Market by Application
10.4.6.2.3 Saudi Arabia Bone Morphogenetic Protein Market by End User
10.4.6.3 U.A.E Bone Morphogenetic Protein Market
10.4.6.3.1 U.A.E Bone Morphogenetic Protein Market by Type
10.4.6.3.2 U.A.E Bone Morphogenetic Protein Market by Application
10.4.6.3.3 U.A.E Bone Morphogenetic Protein Market by End User
10.4.6.4 Rest of Middle East and Africa Bone Morphogenetic Protein Market
10.4.6.4.1 Rest of Middle East and Africa Bone Morphogenetic Protein Market by Type
10.4.6.4.2 Rest of Middle East and Africa Bone Morphogenetic Protein Market by Application
10.4.6.4.3 Rest of Middle East and Africa Bone Morphogenetic Protein Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Bone Morphogenetic Protein Market Overview
10.5.2 South and Central America Bone Morphogenetic Protein Market Forecasts and Analysis
10.5.3 South and Central America Bone Morphogenetic Protein Market Forecasts and Analysis - By Type
10.5.4 South and Central America Bone Morphogenetic Protein Market Forecasts and Analysis - By Application
10.5.5 South and Central America Bone Morphogenetic Protein Market Forecasts and Analysis - By End User
10.5.6 South and Central America Bone Morphogenetic Protein Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Bone Morphogenetic Protein Market
10.5.6.1.1 Brazil Bone Morphogenetic Protein Market by Type
10.5.6.1.2 Brazil Bone Morphogenetic Protein Market by Application
10.5.6.1.3 Brazil Bone Morphogenetic Protein Market by End User
10.5.6.2 Argentina Bone Morphogenetic Protein Market
10.5.6.2.1 Argentina Bone Morphogenetic Protein Market by Type
10.5.6.2.2 Argentina Bone Morphogenetic Protein Market by Application
10.5.6.2.3 Argentina Bone Morphogenetic Protein Market by End User
10.5.6.3 Rest of South and Central America Bone Morphogenetic Protein Market
10.5.6.3.1 Rest of South and Central America Bone Morphogenetic Protein Market by Type
10.5.6.3.2 Rest of South and Central America Bone Morphogenetic Protein Market by Application
10.5.6.3.3 Rest of South and Central America Bone Morphogenetic Protein Market by End User

11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

12. BONE MORPHOGENETIC PROTEIN MARKET, KEY COMPANY PROFILES
12.1. MEDTRONIC
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. MERCK KGAA
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. STRYKER CORPORATION
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. THERMO FISCHER SCIENTIFIC
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. DEPUY SYNTHES( JOHNSON AND JOHNSON)
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. EMBER THERAPEUTICS
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. INTEGRA LIFESCIENCES
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. R AND D SYSTEMS
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. SMITH AND NEPHEW
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. ZIMMER BIOMET HOLDINGS, INC.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments

13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Medtronic
2. Merck KGaA
3. Stryker Corporation
4. Thermo Fischer Scientific
5. DePuy Synthes(Johnson and Johnson)
6. Ember Therapeutics
7. Integra LifeSciences
8. R and D Systems
9. Smith and Nephew
10. Zimmer Biomet Holdings, Inc.
TIPRE00006919
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.